Showing results (1581-1590 of 1,739) with videos related to
Sort By:
Pageof 174
Pulmonary Circulation|May 11, 2016
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolamCorina Becker, Reiner Frey, Sigrun Unger, et al.Pulmonary Circulation|May 11, 2016
Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without foodSoundos Saleh, Reiner Frey, Corina Becker, et al.Pulmonary Circulation|May 11, 2016
Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairmentSoundos Saleh, Corina Becker, Reiner Frey, et al.Pulmonary Circulation|June 3, 2016
Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomyDaniel T Matthews, Catherine N Le, Ivan M Robbins, et al.Pulmonary Circulation|June 3, 2016
Reactive oxygen species-associated molecular signature predicts survival in patients with sepsisChristian Bime, Tong Zhou, Ting Wang, et al.Pulmonary Circulation|June 3, 2016
Pulmonary arterial hypertension in primary amyloidosisMeghan M Cirulis, Lyska L Emerson, David A Bull, et al.Pulmonary Circulation|July 10, 2014
Coagulation and the vessel wall in pulmonary embolismSherin Alias, Irene M LangPulmonary Circulation|July 10, 2014
A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Gerald Maarman, Sandrine Lecour, Ghazwan Butrous, et al.Pulmonary Circulation|July 10, 2014
Transient receptor potential channels and regulation of lung endothelial permeabilityPatricia C Villalta, Mary I TownsleyPulmonary Circulation|July 10, 2014
Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertensionJennifer S Grant, Ian Morecroft, Yvonne Dempsie, et al.Pageof 174